에 대한 최신 뉴스 Janux Therapeutics (NASDAQ:JANX) 주식

Janux Therapeutics

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Mid Cap

News

Movers

Trading Ideas

$BTC

ASAN

BTDR

FIVE

JANX

NBIS

NVCR

SOUN

VSCO

ZETA

이 10개 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?

사운드하운드 및 아사나는 지난주 최고 성과를 보여준 10개 중형주 중 일부 (12월 2일-6일)

Janux Therapeutics Inc

Ascendiant Capital analyst Edward Woo maintains Alzamend Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) with a Buy and lowers the price target from $35 to $32.

Price Target

Analyst Ratings

ALZN

Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $32

HEICO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HEI#NYSE">HEI</a>) will release its fourth-quarter financial results, after the <a href="https://www.benzinga.com/quote/hei/earnings">closing bell, on Tuesday, Dec. 17</a>.
Analysts expect the Hollywood, Florida-based retailer to report quarterly earnings at 98 cents per share, up from 74 cents per share in the year-ago period. Heico projects quarterly revenue of $1.03 billion, compared to $936.45 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Aug 26, the company reported upbeat earnings for its third quarter.
Heico shares gained 0.6% to close at $256.89 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/HEI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Truist Securities analyst Michael Ciarmoli maintained a Buy rating and raised the price target from $264 to $282 on Oct. 18. This analyst has an accuracy rate of 82%.</li>
<li>Morgan Stanley analyst Kristine Liwag maintained an Equal-Weight rating and boosted the price target from $245 to $265 on Oct. 18. This analyst has an accuracy rate of 71%.</li>
<li>B of A Securities analyst Ronald Epstein maintained a Buy rating and raised the price target from $250 to $285 on Sept. 19. This analyst has an accuracy rate of 61%.</li>
<li>Deutsche Bank analyst Scott Deuschle maintained a Buy rating and increase the price target from $235 to $271 on Sept. 4. This analyst has an accuracy rate of 70%.</li>
<li>RBC Capital analyst Ken Herbert maintained an Outperform rating and increased the price target from $250 to $272 on Aug. 28. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying HEI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="408" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16042422/image-120-1024x408.png" alt="" class="wp-image-693386" style="width:530px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16042422/image-120-1024x408.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16042422/image-120-300x119.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16042422/image-120-768x306.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16042422/image-120.png 1512w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

Earnings

Markets

Heico Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) with a Buy and lowers the price target from $9 to $8.5.

SURG

Ascendiant Capital Maintains Buy on Surgepays, Lowers Price Target to $8.5

Ascendiant Capital analyst Edward Woo maintains Genasys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNSS#NASDAQ">GNSS</a>) with a Buy and raises the price target from $4.75 to $5.5.

GNSS

Ascendiant Capital Maintains Buy on Genasys, Raises Price Target to $5.5

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Zedge, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZDGE#NYSE">ZDGE</a>) to report quarterly earnings at 3 cents per share on revenue of $7.28 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Zedge shares gained 2.6% to $2.7999 in after-hours trading.</li>
<li>Analysts expect Compass Minerals International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) to post a quarterly loss at 45 cents per share on revenue of $209 million after the closing bell. Compass Minerals International shares gained 4.8% to $13.69 in the after-hours trading session.</li>
<li>The Western Union Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WU#NASDAQ">WU</a>) announced a new $1 billion share repurchase program. Western Union shares gained 1.7% to $10.94 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>After the closing bell, Mitek Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITK#NASDAQ">MITK</a>) is projected to post quarterly earnings at 17 cents per share on revenue of $41.31 million. Mitek Systems shares gained 1.4% to $8.90 in the after-hours trading session.</li>
<li>Analysts expect RCI Hospitality Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICK#NASDAQ">RICK</a>) to earn 37 cents per share on revenue of $72.98 million for the latest quarter. The company will release earnings after the markets close. RCI Hospitality shares gained 1.5% to $52.85 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42482639/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 6% Dividend Yields</a></li>
</ul>

Pre-Market Outlook

MITK

RICK

ZDGE

Western Union, Compass Minerals International And 3 Stocks To Watch Heading Into Monday

<h3>Companies Reporting Before The Bell</h3>
• Zedge (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZDGE#AMEX">ZDGE</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $7.28 million. 
<h3>Companies Reporting After The Bell</h3>
• Quipt Home Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QIPT#NASDAQ">QIPT</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $65.75 million. 
• Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $5.31 million. 
• Red Cat Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) is expected to report quarterly loss at $0.09 per share on revenue of $4.13 million. 
• Mitek Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITK#NASDAQ">MITK</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $41.30 million. 
• RCI Hospitality Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICK#NASDAQ">RICK</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $72.98 million. 
• Ark Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKR#NASDAQ">ARKR</a>) is estimated to report earnings for its fourth quarter. 
• Mama`s Creations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMA#NASDAQ">MAMA</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $30.05 million. 
• Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) is likely to report quarterly loss at $0.52 per share on revenue of $208.68 million. 
• Ocean Power Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#AMEX">OPTT</a>) is projected to report earnings for its second quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARKR

MAMA

OPTT

QIPT

RCAT

STRM

Earnings Scheduled For December 16, 2024

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) said on Friday that the Cybertruck can now charge up to 325 kW on select V4 supercharger posts, making the charging process faster for its owners. 
What Happened: &#8220;Rollout in progress,&#8221; the company wrote on social media platform X.
Cybertruck customers can charge up to 325 kW at Lebec or Santa Ynez in California, Melissa in Texas, and Harrison in New York, among others. More locations will be added in the future, the company said. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/cybertruck?ref_src=twsrc%5Etfw">@cybertruck</a> can now charge up to 325kW on select V4 Supercharger posts. Rollout in progress.
&mdash; Tesla Charging (@TeslaCharging) <a href="https://twitter.com/TeslaCharging/status/1867760084400623864?ref_src=twsrc%5Etfw">December 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
While V4 supercharging posts are capable of charging up to 500 kW on the V4 cabinet, they can charge only up to 325 kW on existing V3 cabinets, Max de Zegher, Tesla's Director of Charging, North America, said. The first charging sites with V4 Cabinets are expected to open in 2025. 
Tesla superchargers currently have a maximum charging rate of only 250 kW.&nbsp;However, the company is running a trial and trying to increase it on certain superchargers, Cybertruck lead engineer Wes Morrill <a href="https://www.benzinga.com/news/24/08/40179628/tesla-attempts-trial-to-increase-maximum-charging-rate-of-cybertrucks-on-supercharger-network">said in August</a>.
Why It Matters:&nbsp;As of the end of the third quarter, Tesla had 6,706 supercharger stations around the globe and 62,421 connectors.
During Tesla's annual shareholder meeting in June, Tesla CEO&nbsp;Elon Musk&nbsp;slammed rumors of the&nbsp;<a href="https://www.benzinga.com/news/24/05/38757383/elon-musk-announces-500m-investment-in-teslas-supercharger-network-expansion-in-2024" target="_blank" rel="noreferrer noopener">death of its supercharger network&nbsp;</a>following a&nbsp;<a href="https://www.benzinga.com/news/24/10/41200538/tesla-supercharger-network-growth-slows-sequentially-ev-giant-adds-2-800-stalls-in-q3" target="_blank" rel="noreferrer noopener">major layoff in April&nbsp;</a>as "greatly exaggerated." Tesla will invest $500 million in expanding the network this year, Musk then said.
Tesla's company-wide layoffs in April impacted&nbsp;<a href="https://www.benzinga.com/news/24/05/38846223/elon-musk-fired-supercharger-chief-rebecca-tinucci-and-her-entire-team-after-she-refused-to-lay-off" target="_blank" rel="noreferrer noopener">500 members of the supercharging team</a>&nbsp;and&nbsp;Rebecca Tinucci, Tesla's then Senior Director of Charging Infrastructure, left the company.
Tesla&#8217;s Cybertruck has less range as compared to certain of its other offerings such as the Model S all-wheel drive. The company is planning to start production of a <a href="https://www.benzinga.com/news/24/07/40009883/senior-tesla-executive-reveals-cybertruck-range-extender-will-not-be-removable-to-avoid-safety-risks">range extender for the truck in mid-2025</a>. The range extender is an alternate battery pack that can be fit into the truck bed. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42501487/cybertruck-production-rate-was-reduced-even-before-decembers-production-pause-says-tesla-researcher">Tesla&#8217;s Cybertruck Production Rate Was Reduced Even Before December&#8217;s Pause, Says Researcher</a></li>
</ul>
Photo courtesy of Tesla

Tech

TSLA

Tesla Says Cybertruck Drivers Can Now Get Max Charging Rate Of Up To 325 kW On Select V4 Supercharger Posts

President-elect Donald Trump&#8216;s Former U.S. Secretary of State Mike Pompeo has thrown his support behind Nippon Steel Corp.&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NPSCY#OTC">NPSCY</a>) &nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/NISTF#OTC">NISTF</a>)&nbsp;proposed $14.9 billion acquisition of United States Steel Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), arguing the deal would strengthen America&#8217;s position <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42295766/u-s-steel-stock-falls-as-trump-pledges-to-block-nippon-steel-acquisition">against Chinese market dominance</a>.
What Happened: In an opinion piece published in The Wall Street Journal <a href="https://www.wsj.com/opinion/america-must-approve-the-nippon-steel-deal-national-security-china-900b2b5c?mod=hp_opin_pos_6#cxrecs_s">on</a> Friday, Pompeo, who now serves as a strategic adviser to Nippon Steel, emphasized that the transaction would enhance U.S. national and economic security while protecting American jobs.
The deal faces significant opposition from both President Joe Biden and Trump. According to Bloomberg sources, Biden is expected to block the acquisition on national security grounds when the Committee on Foreign Investment in the United States refers its <a href="https://www.benzinga.com/news/global/24/12/42425695/biden-set-to-block-us-steel-sale-to-nippon-steel-report">decision later this month</a>.
Pompeo countered these concerns, stating that blocking the deal would &#8220;undermine America&#8217;s national security by diminishing our ability to maintain robust and competitive domestic steel production.&#8221; He highlighted Nippon Steel&#8217;s commitment to invest $2.7 billion in union-represented local steel facilities.
U.S. Steel spokesperson Amanda Malkowski has previously <a href="https://www.benzinga.com/news/global/24/12/42425695/biden-set-to-block-us-steel-sale-to-nippon-steel-report">defended the transaction</a>, stating that &#8220;this transaction should be approved on its merits.&#8221; Nippon Steel expressed confidence in the American legal system, indicating it would pursue legal action if necessary.
See Also: <a href="https://www.benzinga.com/tech/24/12/42501918/teslas-texas-lithium-plant-begins-operations-amid-market-oversupply">Tesla&#8217;s Texas Lithium Plant Begins Operations Amid Market Oversupply</a>
Why It Matters: The Japanese steelmaker&#8217;s proposed acquisition comes amid growing concerns about China&#8217;s steel overproduction and its <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42295766/u-s-steel-stock-falls-as-trump-pledges-to-block-nippon-steel-acquisition">impact on global markets</a>. 
Biden has until Dec. 22 or 23 to receive CFIUS&#8217;s referral and must announce his decision within 7 days. U.S. Steel shares have experienced volatility as investors react to developments <a href="https://www.benzinga.com/news/global/24/12/42425695/biden-set-to-block-us-steel-sale-to-nippon-steel-report">surrounding the proposed acquisition</a>.
In November after his election victory, Trump made a declaration in a&nbsp;<a href="https://truthsocial.com/@realDonaldTrump/posts/113455540757405917" target="_blank" rel="noreferrer noopener">post</a>&nbsp;on Truth Social, stating, "I will not be inviting former Ambassador Nikki Haley, or former Secretary of State Mike Pompeo, to join the Trump Administration, which is currently in formation."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42501530/ex-google-ceo-eric-schmidt-sees-ai-drones-as-the-future-of-warfare-but-stresses-need-for-meaningful-human-control">Ex-Google CEO Eric Schmidt Sees AI Drones As The Future Of Warfare But Stresses Need For &#8216;Meaningful Human Control&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Global

NISTF

NPSCY

Trump's Ex-Secretary Of State Mike Pompeo Backs Nippon Steel's $14.9B Acquisition Of US Steel Citing National Security Concerns

The Financial Accounting Standards Board's new accounting rules for cryptocurrencies will go into effect on Monday, making it easier for businesses to account for the value of their holdings on their balance sheets and encouraging adoption.
What happened: The <a href="https://www.benzinga.com/markets/cryptocurrency/23/12/36219302/new-crypto-accounting-standards-to-boost-transparency-for-corporate-investors-like-microst">Accounting Standards Update,</a>&nbsp; announced in December of last year in response to widespread stakeholder feedback, will allow firms to report cryptocurrencies at fair value, or simply their current value, recognizing them under the company's net income.
Previously, cryptocurrencies were treated as indefinite-lived intangible assets, meaning that companies had to account for impairment charges.&nbsp;
Companies were required to write down the value of their holdings if the value fell below the original buying price, while the opposite was not true in the case of an unrealized gain. Instead, gains could only be reported if the holdings were sold.
Put simply, companies could only value cryptocurrencies at the price they bought, accounting for only the decreases but not the increases.
The concern from stakeholders was that such a model does not give investors "decision-useful information."
Under the new rules, companies will be required to report the fair market value of their positions, capturing both unrealized gains and losses on a quarterly basis.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42500002/massive-crypto-exchange-witnesses-unusual-100-million-bitcoin-activity">Massive Crypto Exchange Witnesses Unusual $100 Million Bitcoin Activity</a>
Why It Matters: The accounting adjustment allows firms to report more accurately the economic impact of cryptocurrency holdings on their overall financial position.
Furthermore, because they are not required to sell their holdings to declare gains, the HODLing approach may gain traction, helping boost cryptocurrency prices.&nbsp;
The rule change comes at a time when corporate adoption of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), the world's largest cryptocurrency, was gaining traction.
Following in the footsteps of MicroStrategy Inc., the <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42391481/microstrategy-acquires-21b-worth-of-bitcoin-total-holdings-now-exceed-423000-btc#:~:text=MicroStrategy%20Acquires%20%242.1B%20Worth,(NASDAQ%3AMSTR)%20%2D%20Benzinga">market leader</a> with over <a href="https://bitcointreasuries.net/">$44.58 billion</a> worth of Bitcoin on its balance sheet, companies like MARA Holdings and Semler Scientific have been <a href="https://www.benzinga.com/24/12/42387102/mara-holdings-raises-850-million-in-0-convertible-notes-offering-a-40-premium-over-current-share-price#:~:text=According%20to%20Benzinga%2C%20MARA%20has,on%20Jan.%209%2C%202023.">steadily adding the leading coin</a> to their reserves lately.
In fact, it was MicroStrategy Chairman Michael Saylor who <a href="https://www.benzinga.com/23/09/34450116/fasb-clears-the-path-for-corporate-bitcoin-adoption">took the lead</a> in advocating for such an accounting adjustment from the Financial Accounting Standards Board.
Price Action:&nbsp; At the time of writing, Bitcoin was exchanging hands at $105,068.03, up 3.20% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42499633/exclusive-eric-trump-declares-bitcoin-the-future-details-tax-free-crypto-goals-for-trump-presidency">Eric Trump Declares Bitcoin The Future, Details Tax-Free Crypto Goals For Trump Presidency</a></li>
</ul>
Photo courtesy: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

New Crypto Accounting Standards Go Into Effect Today: Will They Boost Bitcoin's Corporate Adoption?

The recent murder of&nbsp;UnitedHealthcare&nbsp;CEO&nbsp;Brian Thompson&nbsp;has sparked a debate about the state of the U.S. healthcare insurance system. Experts are urging the company to address three key issues.
What Happened: Andrew Witty, the current CEO of UnitedHealth Group, has emphasized the pressing need for reform in the healthcare system. In a New York Times op-ed, he shared his difficulty in understanding the &#8220;unconscionable act&#8221; and the animosity faced by his team. He stressed the collective duty of employers, governments, and insurers to demystify insurance coverage and decision-making processes.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42483873/sylvester-stallone-gifts-a-knockout-25-million-hamptons-estate-to-his-daughters-another-addition-to-his-curated-property-portfolio?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Sylvester Stallone Gifts A Knockout $25 Million Hamptons Estate To His Daughters – Another Addition To His Curated Property Portfolio</a>
Caitlin Donovan&nbsp;from the Patient Advocate Foundation pointed out the opacity in insurance coverage, remarking, &#8220;Everything&nbsp;is buried under layers of&nbsp;everything else,&#8221; , MarketWatch <a href="https://www.marketwatch.com/story/unitedhealth-group-ceo-says-healthcare-needs-fixing-start-with-these-3-problems-in-claims-and-patient-costs-experts-say-e60fc0e9?ref=biztoc.com">reported</a>&nbsp;on Monday. 
This complexity often results in patient frustration and financial burden.
Donovan identifies key issues in the healthcare system, such as escalating insurance premiums, a rise in claim denials, and insufficient advance notice of coverage. Furthermore, the incorporation of AI in claim processing has added to the complexity, complicating patient efforts to contest denials.
The process of resolving issues with&nbsp;medical bills and insurance-claim denials&nbsp;has become increasingly complex, requiring more time and effort. Comprehensive industrywide claim-denial rates are difficult to obtain, but some data suggests that&nbsp;insurers denied around 17% of&nbsp;claims in 2021.
Although legislation such as the No Surprises Act has been introduced to prevent surprise medical bills, the implementation of advance cost estimates is still pending. The use of artificial intelligence in claim coverage has further complicated the process of disputing claim denials.
Why It Matters: The tragic death of Thompson&nbsp;has cast a spotlight on the practices within the insurance industry. UnitedHealthcare&nbsp;is <a href="https://www.benzinga.com/24/12/42365853/unitedhealthcare-faces-tough-questions-following-insurance-business-ceos-tragic-death">under intense scrutiny</a>, although no direct connection between Thompson&#8217;s murder and industry tensions has been confirmed. Law enforcement noted that bullet casings at the crime scene were inscribed with words like "deny" and "delay," terms frequently linked to insurance claim practices.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42499950/crypto-analyst-shiba-inu-price-set-for-massive-surge-could-go-up-sixfold?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Crypto Analyst: Shiba Inu Price Set For Massive Surge, Could Go Up Sixfold</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Analyst Color

Health Care

General

UnitedHealthcare CEO's Tragic Death Sparks Urgent Debate Over US Insurance Industry Reform: Expert Says 'Everything Is Buried Under Layers Of Everything Else'

Performance Brokerage Services, the leader in dealership buy-sell activity, announces the sale of North Branch Chevrolet in Minnesota from Lithia &amp; Driveway (LAD) to Tyler Kadlec of Tom Kadlec Automotive.
IRVINE, Calif., Dec. 16, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4325228-1&amp;h=568649336&amp;u=http%3A%2F%2Fwww.performancebrokerageservices.com%2F&amp;a=Performance+Brokerage+Services">Performance Brokerage Services</a>, North America's highest volume dealership brokerage firm, is proud to represent Lithia &amp; Driveway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) on the sale of North Branch Chevrolet in North Branch, Minnesota to Tyler Kadlec of Tom Kadlec Automotive.
Lithia &amp; Driveway started from humble beginnings when Walt DeBoer founded a Chrysler-Plymouth-Dodge dealership in Ashland, Oregon in 1946. Walt's son, Sid DeBoer, transformed the dealership group into Lithia Motors, Inc., a publicly traded company in 1996. Now a third-generation company, Lithia &amp; Driveway is run by Sid's son, Bryan DeBoer, CEO &amp; President, and ranked #1 on the 2024 Automotive News Top 150 Dealership Groups based on 2023 new vehicle retail sales units.

Lithia & Driveway Sells Minnesota Chevrolet Dealership to Tom Kadlec Automotive

Analysts predict a good year for gold in 2025 after it&#8217;s poised for the best annual performance in over a decade in 2024. However, Michael Saylor, co-founder and executive chairman of MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), has <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42413650/michael-saylor-urges-us-to-ditch-gold-for-bitcoin-sell-the-past-own-the-future">called for a dramatic shift </a>in U.S. economic strategy, urging the country to abandon gold as a reserve asset in favor of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: The World Gold Council in its 2025 outlook has outlined three scenarios for the precious metal in the upcoming year. According to them, gold will &#8220;remain rangebound&#8221; if existing market expectations are correct.
Explaining its rationale for the rangebound assertion, the council notes that &#8220;a combination of higher rates and lower economic growth could negatively affect investors and consumers.&#8221;
On the flip side, &#8220;significantly lower interest rates or a deterioration in geopolitics or market conditions will improve gold's performance.&#8221;
JPMorgan has said that it expects gold prices to &#8220;find continued support from central banks, particularly in emerging markets. Critically, gold—the original safe-haven asset—can serve as an attractive hedge against both geopolitical risk and uncertainty around sovereign debt and deficits.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42413650/michael-saylor-urges-us-to-ditch-gold-for-bitcoin-sell-the-past-own-the-future">Michael Saylor Urges US To Ditch Gold For Bitcoin: &#8216;Sell The Past, Own The Future&#8217;</a>
Goldman Sachs, on the other hand, forecasts gold prices will reach $2,700 by early next year, &#8220;buoyed by interest rate cuts by the Federal Reserve and gold purchases by emerging market central banks. The metal could get an additional boost if the U.S. imposes new financial sanctions or if concerns mount about the U.S. debt burden.&#8221;
Bitcoin Bulls Disagree
Despite a largely positive outlook for gold in 2025, few Bitcoin bulls think differently. Speaking on an episode of the Galaxy Brains podcast, Saylor labeled gold as a "shiny dead rock.&#8221;
"If you want to elevate the U.S.&#8217;s economic leadership in the world, there are two very simple strategies," Saylor said. "Dump the gold and buy Bitcoin."
He suggested that replacing gold with Bitcoin as a strategic reserve asset would allow the U.S. to demonetize gold—an asset heavily held by rival nations—and capitalize on Bitcoin&#8217;s growth potential.
Price Action: Gold spot prices have risen by 28.63% year-to-date, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>. This is gold&#8217;s best performance since 2007 when gold surged by over 31%.
Here&#8217;s how a few other gold ETFs have performed this year.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>ETFs</td>
<td>YTD Performance</td>
</tr>
<tr>
<td>Franklin Responsibly Sourced Gold ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FGDL#NYSE">FGDL</a>)</td>
<td>29.07%</td>
</tr>
<tr>
<td>iShares Gold Trust Micro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAUM#NYSE">IAUM</a>)</td>
<td>28.52%</td>
</tr>
<tr>
<td>SPDR Gold MiniShares Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLDM#NYSE">GLDM</a>)</td>
<td>28.55%</td>
</tr>
<tr>
<td>Aberdeen Physical Gold Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGOL#NYSE">SGOL</a>)</td>
<td>28.46%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final-1024x576.png" alt="" class="wp-image-693140" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020045/Gold-ETf-final.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
In comparison, Bitcoin ETFs have surged over four times during the same period.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>ETF</td>
<td>YTD Performance</td>
</tr>
<tr>
<td>Franklin Responsibly Sourced Gold ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#NYSE">FBTC</a>)</td>
<td>138.83%</td>
</tr>
<tr>
<td>Grayscale Bitcoin Mini Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITC#NYSE">BITC</a>)</td>
<td>123.13%</td>
</tr>
</tbody>
</table>
</figure>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final-1024x576.png" alt="" class="wp-image-693139" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/16020016/Bitcoin-ETfs-final.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42495307/charlie-munger-identified-this-stock-30-years-ago-after-warren-buffett-passed-on-it-heres-how-it-is-doing-as-it-accomplishes-four-milestones-in-its-current-quarter">Charlie Munger Identified This Stock 30 Years Ago After Warren Buffett Passed On It: Here&#8217;s How It Is Doing Now</a></li>
</ul>
Photo courtesy: Shutterstock

Commodities

Economics

ETFs

BITC

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

FGDL

GLDM

IAUM

MSTR

SGOL

Gold Poised For Its Best Year In A Decade While Bitcoin Surges: Analysts Eye 2025 As A Golden Era For Precious Metal Amid Michael Saylor's Push For BTC As A Reserve Asset

<ul>
<li>Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024.</li>
<li>Proceeds from the completed first tranche to be primarily used to advance Inventiva's Phase III, NATiV3 clinical trial evaluating lanifibranor in patients with MASH.</li>
<li>Appointment of Mark Pruzanski as new Chairman of the Board of Directors and Srinivas Akkaraju as new member of the Board of Directors.</li>
</ul>

Inventiva Secures €21.4M, Successfully Completes First Tranche Of Multi-Tranche €348M Financing

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has initiated production at its lithium refinery in Robstown, Texas. The company announced on Monday that raw materials were successfully fed through the facility&#8217;s kiln for the first time.
What Happened: The Corpus Christi-area plant represents the large-scale battery-grade lithium refinery in the United States and pioneers an acid-free refining process. 
This development comes as global lithium prices have plummeted from their 2022 peak of $80,000 per ton to below $10,000, <a href="https://www.benzinga.com/24/12/42433867/lithium-producers-brace-for-prolonged-oversupply-stalled-prices">according to industry data</a>.
&#8220;Increasing lithium refining capacity is critical to a sustainable energy economy<a href="https://x.com/tesla_na/status/1868378548890906887/photo/1" target="_blank" rel="noreferrer noopener"></a>,&#8221; Tesla stated on X.
The timing of Tesla&#8217;s refinery launch coincides with a projected lithium oversupply that UBS analysts expect to persist until 2027. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This week, we fed raw material through our kiln of our Lithium Refinery outside of Corpus Christi, TX for the very first time! Increasing lithium refining capacity is critical to a sustainable energy economy <a href="https://t.co/TCumnzEEIB">pic.twitter.com/TCumnzEEIB</a>
&mdash; Tesla North America (@tesla_na) <a href="https://twitter.com/tesla_na/status/1868378548890906887?ref_src=twsrc%5Etfw">December 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/tech/24/12/42501530/ex-google-ceo-eric-schmidt-sees-ai-drones-as-the-future-of-warfare-but-stresses-need-for-meaningful-human-control">Ex-Google CEO Eric Schmidt Sees AI Drones As The Future Of Warfare But Stresses Need For &#8216;Meaningful Human Control&#8217;</a>
Why It Matters: Despite challenging market conditions, Tesla CEO Elon Musk has remained optimistic about battery production capabilities, recently noting that <a href="https://www.benzinga.com/news/24/01/36488565/tesla-ceo-elon-musk-calms-fears-of-critical-material-shortages-says-battery-production-happening-at">battery manufacturing is growing</a> &#8220;almost at several times the rate of vehicle production.&#8221;
The Texas facility&#8217;s opening represents a strategic move in the U.S. battery supply chain, supported by the Inflation Reduction Act&#8217;s push for domestic production. 
This development occurs as Chinese companies <a href="https://www.benzinga.com/24/12/42433867/lithium-producers-brace-for-prolonged-oversupply-stalled-prices">maintain their market dominance</a> despite current low prices, with some global producers operating at a loss, according to Martin Jackson, head of battery raw materials at CRU.
S&amp;P Global forecasts lithium prices to stabilize between $9,900 and $11,600 per ton through 2026, suggesting a challenging but potentially stabilizing market environment as Tesla&#8217;s new facility <a href="https://www.benzinga.com/24/12/42433867/lithium-producers-brace-for-prolonged-oversupply-stalled-prices">ramps up operations</a>.
Price Action: Tesla stock closed Friday at $436.23, rising 4.34%. Year-to-date, the stock has soared 75.60%. The stock reached a 52-week high of $436.30, while its 52-week low sits at $138.80, with a price-to-earnings ratio of 119.61, according to <a href="https://pro.benzinga.com/dashboard">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42501487/cybertruck-production-rate-was-reduced-even-before-decembers-production-pause-says-tesla-researcher">Tesla&#8217;s Cybertruck Production Rate Was Reduced Even Before December&#8217;s Pause, Says Researcher</a> </li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tesla's Texas Lithium Plant Begins Operations Amid Market Oversupply

- THRIVE-2 global phase 3 clinical trial evaluated efficacy and safety of veligrotug in patients with chronic thyroid eye disease (TED) -
- Conference call and webcast to be held Monday, December 16, at 8:00 a.m. ET -

VRDN

Reported Friday, Viridian Therapeutics To Report Pivotal THRIVE-2 Data For Veligrotug In Chronic TED Treatment

"Today's FDA approval of UNLOXCYT – the first marketing approval for our company – is a significant milestone both for Checkpoint and for patients with advanced cSCC," said James Oliviero, President and Chief Executive Officer of Checkpoint. "This approval marks Checkpoint's transformation to a commercial-stage company, with the opportunity to compete in a U.S. market estimated to exceed $1 billion annually, where we believe UNLOXCYT offers a differentiated treatment option versus available therapies by binding to PD-L1, rather than programmed death receptor-1 ("PD-1"), to release the inhibitory effects of PD-L1 on the anti-tumor immune response. Additionally, UNLOXCYT has demonstrated the ability to induce antibody-dependent cell-mediated cytotoxicity ("ADCC"), another potential differentiating feature of the drug compared to existing marketed therapies for patients with cSCC."

CKPT

Reported Friday, FDA Approves Checkpoint Therapeutics' UNLOXCYT (cosibelimab-ipdl) For Advanced cSCC Treatment

<ul>
<li>CRENESSITY, the first new treatment available in 70 years to the classic congenital adrenal hyperplasia (CAH) community, offers a paradigm-shifting treatment approach
<ul>
<li>FDA approval supported by data from the largest-ever clinical trial program in pediatric and adult patients with classic CAHCRENESSITY is expected to be commercially available in approximately one week Rare Pediatric Disease Priority Review Voucher granted in connection with approval</li>
</ul>
</li>
</ul>

NBIX

Reported Friday, Neurocrine Biosciences' CRENESSITY Receives FDA Approval, Revolutionizing Treatment For Classic Congenital Adrenal Hyperplasia

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is reportedly gearing up to launch a redesigned AirTag in 2025 with better tracking capabilities and range.
What Happened: In the latest installment of the weekly "Power On" newsletter, Bloomberg columnist Mark Gurman said that the updated AirTag will feature a next-generation ultrawide-band chip, previously seen in iPhone 15.
This will result in AirTag 2 offering a range three times greater than the current model, which can be located from 10 to 30 meters away using Precision Finding.
In addition, the new AirTag is expected to include improved security features, to make it easier for users to locate items to which the AirTag is attached.
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: The much-anticipated 2025 AirTag redesign comes amid ongoing discussions about the device&#8217;s security and privacy implications.
Earlier this year, <a href="https://www.benzinga.com/news/24/03/37764878/apple-loses-motion-to-dismiss-lawsuit-claiming-airtags-are-weapon-of-stalkers-determination-cannot-b">Apple faced a lawsuit</a> alleging that AirTags were being misused by stalkers. The lawsuit, which Apple failed to dismiss, highlighted concerns about the potential misuse of the tracking device.
In response to such concerns, Apple has been working on improving the security features of its AirTags. The upcoming model is expected to address these issues.
However, AirTags have also proven <a href="https://www.benzinga.com/news/23/07/33226618/how-an-apple-airtag-led-to-the-capture-of-a-sneaky-thief">effective in various situations</a>, such as aiding in the recovery of stolen items.
Last month, Apple also introduced a feature allowing users to <a href="https://www.benzinga.com/tech/24/11/41931360/apples-airtag-users-can-now-share-location-with-airlines-for-faster-recovery-of-lost-luggage">share the location of lost</a> items with third parties, such as airlines, through the Find My app.
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech">following this link</a>.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42495579/lawmakers-demand-apple-and-google-remove-tiktok-by-jan-19-what-you-need-to-know?itm_source=parsely-api">Apple, Google Directed To Remove TikTok From Respective App Stores By Jan 19: Here&#8217;s What You Need To Know</a></li>
</ul>
Image via Shutterstock

Media

AAPL

Apple's 2025 AirTag To Feature iPhone 15's Ultrawide-Band Chip For Smarter, Longer-Range Tracking: Report

<ul>
<li>Proposed acquisition strengthens Pharming's late-stage pipeline with a potential first-in-disease asset</li>
<li>Abliva's lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary mitochondrial diseases</li>
<li>Total transaction value of approximately US$66.1 million</li>
<li>No external funding required to fund acquisition and KL1333 development costs</li>
</ul>

PHAR

Pharming Announces $66.1M Cash Offer To Acquire Abliva AB, Strengthening Late-Stage Pipeline

<ul>
<li>Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately equivalent exposure to pirfenidone 801 mg TID1) and deupirfenidone 825 mg TID and successfully demonstrated dose-dependent response</li>
<li>Decline in lung function seen with deupirfenidone 825 mg TID as a monotherapy was -21.5 mL; natural lung function decline expected in healthy adults &gt;60 years is ~-15 to ~-25 mL2; decline in lung function with pirfenidone 801 mg TID was -51.6 mL</li>
<li>Deupirfenidone 825 mg TID showed strong, consistent and durable efficacy with a treatment effect versus placebo of 80.9% with favorable tolerability, while pirfenidone 801 mg TID had a 54.1% treatment effect versus placebo</li>
<li>Deupirfenidone was generally well-tolerated with a favorable adverse event profile at both doses studied</li>
<li>Data support continued development of deupirfenidone and highlight its potential to serve as a new standard-of-care treatment for IPF</li>
<li>Company to host a webcast and conference call today at 9:00am EST / 2:00pm GMT</li>
</ul>

PRTC

PureTech's Phase 2b Trial Of Deupirfenidone Offers Hope For IPF Patients, Achieving Significant Lung Function Preservation

The Dow Jones Industrial Average is down triple digits this afternoon, as traders unpack this morning's jobs data.

S&P 500 Cools From Post-Election Record Highs

Janux Therapeutics (JANX) announced that it has commenced an underwritten public offering of $300M of shares of its common stock or, in lieu of com...

Janux Therapeutics announces $300M common stock offering

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: UnitedHealth (UNH) halted its investor...

Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz

The deal size was increased to $350M from $300M and priced below last closing price of $66.83. BofA, TD Cowen, Stifel, Cantor Fitzgerald and Willia...

Janux Therapeutics 5.32M share Secondary priced at $63.00

Janux Therapeutics prices $350M securities offering

Janux Therapeutics Inc (JANX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 2. Analyst Justi...

Janux Therapeutics Inc's Promising Data and Strategic Advancements Earn a Reiterated Buy Rating

Bank of America Securities analyst Alec Stranahan assigned a Buy rating to the stock on December 3. The company's shares opened today at $67.40. St...

Bank of America Securities Gives a Buy Rating to Janux Therapeutics Inc (JANX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Janux Therapeutics Inc (JANX – Research Report) and ...

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)

In a report released today, Justin Zelin from BTIG maintained a Buy rating on Janux Therapeutics Inc (JANX – Research Report), with a price target ...

BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

Vir Biotechnology Could Be An Early Riser In 2025 With Oncology Data In January

ACMR

AMZN

CCRN

CHWY

CURV

DLTR

KURA

MRVL

MSFT

NXPI

PSTG

ROKU

SNYNF

Small Cap

Opinion

Press Releases

Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb

Janux Therapeutics Announces Updates to Board of Directors

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

Janux Therapeutics Announces Proposed Public Offering

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters' Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

CADL

HALO

ONCY

TSX:ONC

ACADIA Pharmaceuticals Inc. - Common Stock

ACADIA Pharmaceuticals

Arcellx

ADMA Biologics

Alkermes

Alvotech

Apellis Pharmaceuticals, Inc. - Common Stock

Apellis Pharmaceuticals

Biohaven

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Denali Therapeutics

Amicus Therapeutics

Grifols, S.A. - American Depositary Shares

Grifols

Immunovant

Krystal Biotech

MoonLake Immunotherapeutics - Class A Ordinary Shares

MoonLake

PTC Therapeutics

Ultragenyx Pharmaceutical Inc. - Common Stock

Ultragenyx Pharmaceutical

Avidity Biosciences

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

Scholar Rock Holding Corporation - Common Stock

Scholar Rock Holding

SpringWorks Therapeutics, Inc. - common stock

SpringWorks Therapeutics

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Veracyte

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Zai Lab Limited - American Depositary Shares

Zai Lab

Cantor Fitzgerald

Scotiabank

Stifel

Leerink Partners

HC Wainwright & Co.

이 10개 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 네비우스 그룹 N.V.(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIS#NASDAQ">NBIS</a>) 주식은 시트론 리서치(Citron Research)가 이 회사가 차세대 <a href="https://kr.benzinga.com/news/usa/stocks/%EC%8B%9C%ED%8A%B8%EB%A1%A0-%EB%A6%AC%EC%84%9C%EC%B9%98-%EC%97%94%EB%B9%84%EB%94%94%EC%95%84%EA%B0%80-%ED%88%AC%EC%9E%90%ED%95%9C-%EB%84%A4%EB%B9%84%EC%9A%B0%EC%8A%A4-%EC%B0%A8%EC%84%B8%EB%8C%80-ai/" target="_blank" rel="noopener">인공지능(AI) 센세이션</a>이 될 잠재력을 가지고 있다고 강조한 후 67.21% 급등했다.
2. 사운드하운드 AI(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) 주식은 회사가 <a href="https://www.benzinga.com/24/12/42348247/soundhound-ai-shares-were-on-the-rise-today-whats-going-on" target="_blank" rel="noopener">모든 130개 토치스 타코(Torchy&#8217;s Tacos) 매장에 음성 AI 스마트 주문 시스템을 배치했다</a>고 발표한 후 61.22% 상승했다.
3. 비트디어 테크놀로지스 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) 주식은 회사가 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com//node/42342253" target="_blank" rel="noreferrer noopener">생산 및 운영 업데이트</a>를 발표한 후 47.23% 상승했다. 애널리스트들이 <a href="https://www.benzinga.com/quote/btdr/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향 조정</a>했다.
4. 아사나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) 주식은 회사가 예상보다 좋은 재무 결과를 발표하고 여러 <a href="https://www.benzinga.com//node/42369344" target="_blank" rel="noreferrer noopener">애널리스트들이 주가 전망을 상향 조정</a>했다고 보고한 후 44.94% 상승했다.
5. 제눅스 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) 주식은 회사가 <a href="https://www.benzinga.com//node/42294918" target="_blank" rel="noreferrer noopener">전립선암에 대한 JANX007 프로그램</a>의 업데이트된 중간 임상 데이터를 발표한 후 43.75% 상승했다. 애널리스트들이 주가 <a href="https://www.benzinga.com/quote/janx/analyst-ratings" target="_blank" rel="noreferrer noopener">전망을 상향 조정</a>했다.
6. 노보큐어(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) 주식은 회사가 3상 PANOVA-Trial이 주요 엔드포인트를 충족하고 <a href="https://www.benzinga.com//node/42268730" target="_blank" rel="noreferrer noopener">중간 전체 생존율에서 통계적으로 유의미한 개선을 보였다</a>고 발표한 후 39.52% 상승했다.
7. 킹소프트 클라우드 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) 주식은 38.27% 상승했다.
8. 빅토리아 시크릿(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) 주식은 회사가 <a href="https://www.benzinga.com//node/42365539" target="_blank" rel="noreferrer noopener">예상보다 좋은 3분기 결과를 발표했다</a>고 보고한 후 23.64% 급등했다. 애널리스트들이 <a href="https://www.benzinga.com/quote/vsco/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 전망을 상향</a> 조정했다.
9. 제타 글로벌 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) 주식은 회사가 <a href="https://kr.benzinga.com/news/usa/stocks/%EC%A0%9C%ED%83%80-%EA%B8%80%EB%A1%9C%EB%B2%8C-10-%EA%B0%80%EA%B9%8C%EC%9D%B4-%EA%B8%89%EB%93%B1%ED%95%9C-%EC%9D%B4%EC%9C%A0%EB%8A%94/" target="_blank" rel="noopener">추수감사절부터 사이버 먼데이까지 마케팅 플랫폼 사용량이 108% 증가했다</a>고 발표한 후 22.91% 상승했다.
10. 파이브 빌로우(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) 주식은 회사가 <a href="https://www.benzinga.com//node/42349581" target="_blank" rel="noreferrer noopener">예상보다 좋은 3분기 결과를 발표하고</a> 여러 애널리스트들이 주가 전망을 상향 조정한 후 21.61% 상승했다.
다음 읽기:
<a href="https://kr.benzinga.com/news/usa/stocks/%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C-%EB%A3%B0%EB%A3%A8%EB%A0%88%EB%AA%AC-%EB%B0%8F-%EB%A1%9C%EC%BF%A0-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC/" target="_blank" rel="noopener">슈퍼 마이크로, 룰루레몬 및 로쿠 지난주 최고 성과를 보여준 11개 대형주 중 일부 (12월 2일-6일)</a>
<a href="https://kr.benzinga.com/news/usa/stocks/%EC%9D%B8%ED%85%94-%EC%9C%A0%EB%82%98%EC%9D%B4%ED%8B%B0%EB%93%9C%ED%97%AC%EC%8A%A4-%EB%B0%8F-%EB%A1%9C%EC%BC%93%EB%9E%A9-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC/" target="_blank" rel="noopener">인텔, 유나이티드헬스 및 로켓랩 지난주 최악의 성과를 보인 11개 대형주 중 일부 (12월 2일-6일)</a>
사진: Victoria&#8217;s Secret 제공
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Janux Therapeutics

뉴스

에 대한 최신 뉴스 Janux Therapeutics (NASDAQ:JANX) 주식

일요일, 12월 08, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌